Re: Idea for Zenith

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

KOO-KOO2

Rank: Treasurer [?]

Points: 10512 [?]

Votes: 39 Score: 2.3 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Idea for Zenith

in response to

Re: Idea for Zenith

fouremm

posted on Jul 16, 2021 02:51PM

"the RVX preferreds may have a great deal of value at some point."

the "ZHCLF" shares trading on the OTC, do they carry with them the Resverlogix Royalty Preferred Shares that are entitled to dividends in the amount of 6-12 % of Resverlogix's net revenue if any.